Difficulty: Medium
Average Score: 87%
Practice
The following antibiotic is a first-line drug for treatment of Mycobacterium avium complex infection in AIDS patients
Correct answer
B
Rationale
The correct answer is B) Clarithromycin. In treating Mycobacterium avium complex (MAC) infection in AIDS patients, clarithromycin is considered a first-line drug due to its efficacy and tolerability. Clarithromycin is a macrolide antibiotic that has shown good activity against MAC organisms, making it a preferred choice in this context.
A) Clindamycin is not typically used as a first-line treatment for MAC infections in AIDS patients. It is more commonly used for other types of infections.
C) Roxithromycin is not a recommended first-line treatment for MAC infections. Its spectrum of activity may not be as effective as clarithromycin in this specific scenario.
D) Erythromycin, while also a macrolide antibiotic like clarithromycin, is not as commonly used for MAC infections in AIDS patients due to concerns about resistance and tolerability issues.
Educationally, understanding the rationale behind the choice of clarithromycin for treating MAC infections in AIDS patients is crucial for healthcare providers involved in managing such cases. It highlights the importance of selecting appropriate antibiotics based on their spectrum of activity, efficacy, and safety profile in specific patient populations. This knowledge aids in providing optimal care and improving patient outcomes in clinical practice.
A) Clindamycin is not typically used as a first-line treatment for MAC infections in AIDS patients. It is more commonly used for other types of infections.
C) Roxithromycin is not a recommended first-line treatment for MAC infections. Its spectrum of activity may not be as effective as clarithromycin in this specific scenario.
D) Erythromycin, while also a macrolide antibiotic like clarithromycin, is not as commonly used for MAC infections in AIDS patients due to concerns about resistance and tolerability issues.
Educationally, understanding the rationale behind the choice of clarithromycin for treating MAC infections in AIDS patients is crucial for healthcare providers involved in managing such cases. It highlights the importance of selecting appropriate antibiotics based on their spectrum of activity, efficacy, and safety profile in specific patient populations. This knowledge aids in providing optimal care and improving patient outcomes in clinical practice.